Author Correction to: Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy

Author Correction to: PharmacoEconomics (2018) 36(1):91–103 10.1007/s40273-017-0557-6

In the print publication the data in Table 2, has been incorrectly published.

Page 95, Table 2, final row, second column: the mean Advanced treatment annual cost which

previously read

83,249

should read

8324